HOME COMPANY INFORMATION SERVICE AND EQUIPMENT WHO DO WE HELP? INDUSTRY OVERVIEW PAY BILL INVESTOR RELATIONS CONTACT INVESTOR RELATIONS Viemed strategy seeks to re-inforce our position as a leader in the US home respiratory health care industry by improving the quality of life for its patients. Your browser does not support iframes. Your browser does not support iframes. Quick Find Find Find attractive fundamentals discover IR presentation and downloads view investor contacts discover financial reports view NASDAQ stock information view news and events view TSX stock information view annual and special meeting view receive information sign up Investment Highlights The company is well positioned to pursue sustainable growth and profitability through leveraging its brand awareness, realizing operational synergies, expansion of its product and service offerings and pursing growth into new US states not currently covered by Viemed. In a very dynamic healthcare landscape, Viemed has managed to build a strong reputation through successful differentiation based on: Case managers are registered respiratory therapists and assigned to each patient and on call 24/7 Consistent delivery of quality -in service and equipment that requires little servicing Affordability for patients – low monthly service plans vs large cash outlay for costly at home medical devices and most plan costs covered by Medicare and insurance Reduction of re-admissions to facilities reduces cost to taxpayers. Viemed patients have a 5.7% re-admission rate, significantly below industry average of 20% ATTRACTIVE FUNDAMENTALS back to top Strong financial performance Proven clinical results patient outcomes 93% of patients report they breathe better Patients are 3 times more likely to pass away during 90 days after a Chronic Respiratory failure diagnosis if NIV treatment is not obtained Reduction of readmissions to facilities reduces cost to payers - currently estimated at approximately $30,000 per patient of annual savings Viemed patients have on average a 5.4% re-admission rate to hospitals vs a 20% industry standard - a significant saving to hospitals and patients in time and resources Attractive industry growth opportunity At the age of 65, patients qualify for Medicare. 10,000 people turn 65 daily for the next 19 years. Expenditures are expected to grow at a 5.4% CAGR from $54.9 billion to $74.0 billion in 2023 Addressable audience FINANCIAL REPORTS back to top DOWNLOAD 2021 2021 Q3 Financial Statements 2021 Q2 Financial Statements 2021 Q1 Financial Statements 2020 2020 Annual Financial Statements 2020 Q3 Financial Statements 2020 Q2 Financial Statements 2020 Q1 Financial Statements 2019 2019 Annual Financial Statements 2019 Q3 Financial Statements 2019 Q2 Financial Statements 2019 Q1 Financial Statements 2019 Q1 MD&A Notice of Annual Meeting of Shareholders - May 13, 2019 Information Circular 2019 2018 2018 Annual Financial Statements 2018 Year ended MD&A 2018 Q3 Financial Statements 2018 Q3 MD&A 2018 Q2 Financial Statements 2018 Q2 MD&A 2018 Q1 Financial Statements 2018 Q1 MD&A 2017 2017 & 2016 Annual Financial Statements 2017 Year ended MD&A 2017 Q3 Condensed combined interim financial statements 2017 Q3 MD&A 2016 2016 Year ended Combined financial statements 2016 Year ended MD&A ANALYST COVERAGE Acumen Capital Finance Partners, Ltd. Nick Corcoran Beacon Securities Unlimited Doug Cooper Bloom Burton Securities, Inc. Prasath Pandurangan Lake Street Capital Markets Brooks O’Neil RBC Capital Markets Frank Morgan REGULATORY FILINGS Viemed’s public filings, including news releases, financial reports, management proxy circulars, and annual information forms, are available from The System for Electronic Document Analysis and Retrieval (SEDAR), an electronic filing system for Canadian publicly traded companies and the electronic data gathering, analysis and retrieval (EDGAR), an electronic filing system for US listed companies. Access all of Viemed’s TSX regulatory filings on SEDAR: https://sedar.com/homepage_en.htm Access all of Viemed’s NASDAQ regulatory filings on EDGAR: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001729149&owner=exclude&count=40 NEWS AND EVENTS back to top EVENTS 2021 16 Nov 2021 Stifel 2021 - Viemed Presentation - Webcast 2 November 2021 2021 Third Quarter Earnings Conference Call Audio Player 00:00 00:00 Use Up/Down Arrow keys to increase or decrease volume. 2 November 2021 Transcript: 2021 Third Quarter Earnings Conference Call 3 August 2021 2021 Second Quarter Earnings Conference Call Audio Player 00:00 00:00 Use Up/Down Arrow keys to increase or decrease volume. 3 August 2021 Transcript: 2021 Second Quarter Earnings Conference Call 4 May 2021 2021 First Quarter Earnings Conference Call Audio Player 00:00 00:00 Use Up/Down Arrow keys to increase or decrease volume. 4 May 2021 Transcript: 2021 First Quarter Earnings Conference Call 3 March 2021 2020 Year End Earnings - Conference Call Audio Player 00:00 00:00 Use Up/Down Arrow keys to increase or decrease volume. 3 March 2021 Transcript: Year End 2020 Earnings Conference Call 2020 5 November 2020 2020 Third Quarter Earnings Conference Call Audio Player 00:00 00:00 Use Up/Down Arrow keys to increase or decrease volume. 5 November 2020 Transcript: 2020 Third Quarter Earnings Conference Call 5 August 2020 2020 Second Quarter Earnings Conference Call Audio Player 00:00 00:00 Use Up/Down Arrow keys to increase or decrease volume. 5 August 2020 Transcript: 2020 Second Quarter Earnings Conference Call 27 May 2020 Viemed Investor Presentation - Webcast 5 May 2020 2020 First Quarter Earnings Conference Call Audio Player 00:00 00:00 Use Up/Down Arrow keys to increase or decrease volume. 5 May 2020 Transcript: 2020 First Quarter Earnings Conference Call 2019 3 March 2020 2019 Year End Earnings - Conference Call Audio Player 00:00 00:00 Use Up/Down Arrow keys to increase or decrease volume. 5 December 2019 Viemed Healthcare, Inc. - Webcast 5 November 2019 2019 Third Quarter Earnings Conference Call Audio Player 00:00 00:00 Use Up/Down Arrow keys to increase or decrease volume. 5 November 2019 Transcript: 2019 Third Quarter Earnings Conference Call 9 August 2019 2019 Second Quarter Earnings Conference Call Audio Player 00:00 00:00 Use Up/Down Arrow keys to increase or decrease volume. 9 August 2019 Transcript: 2019 Second Quarter Earnings Conference Call 7 May 2019 2019 First Quarter Earnings Conference Call Audio Player 00:00 00:00 Use Up/Down Arrow keys to increase or decrease volume. 7 May 2019 Transcript: 2019 First Quarter Earnings Conference Call 1 April 2019 Spring Investor Summit Conference - Webcast 27 March 2019 Understanding the business and growth path of Viemed - Conference Call 28 February 2019 2018 Year End Earnings - Conference Call Audio Player 00:00 00:00 Use Up/Down Arrow keys to increase or decrease volume. 28 February 2019 Transcript: Year End 2018 Earnings Conference Call 2018 5 November 2018 2018 Third Quarter Earnings – Conference Call Audio Player 00:00 00:00 Use Up/Down Arrow keys to increase or decrease volume. 5 November 2018 Transcript: 2018 Third Quarter Earnings Conference Call 14 August 2018 2018 Second Quarter Earnings – Conference Call Audio Player 00:00 00:00 Use Up/Down Arrow keys to increase or decrease volume. 14 August 2018 Transcript: 2018 Second Quarter Earnings Conference Call 15 June 2018 The Motley Fool Hidden Gems - Interview with CEO and COO 6 June 2018 Proactive Investors Stocktube - Interview with CEO 8 May 2018 2018 Quarterly Earnings – Conference Call Audio Player 00:00 00:00 Use Up/Down Arrow keys to increase or decrease volume. 8 May 2018 Transcript: 2018 Quarterly Earnings Conference Call 13 March 2018 2017 Year End Financial Results - Conference Call Audio Player 00:00 00:00 Use Up/Down Arrow keys to increase or decrease volume. 22 February 2018 Viemed Healthcare Investor - Webcast SPECIAL RELEASES 2020 6 May 2020 Notice of Annual & Special meeting of shareholders to be held on June 11, 2020 and Management Information Circular 2018 4 October 2018 A Recent KPMG Study Supports that Home Non-invasive Ventilation for COPD Reduces Costs and Hospitalizations 27 July 2018 KPMG Study - A US based cost study analysis assessing the mortality, costs, and hospitalization rates for NIV intervention Your browser does not support iframes. Your browser does not support iframes. ANNUAL AND SPECIAL MEETING back to top PROXY STATEMENTS AND NOTIFICATIONS 30 April 2021 2021 Management Information and Proxy Circular 30 April 2021 2021 Form of Proxy 30 April 2021 2021 Notice and Access Notification ANNUAL REPORT 30 April 2021 2020 Annual Report IR PRESENTATION AND DOWNLOADS back to top PRESENTATION DECK & FACT SHEET The following information was accurate at the time of posting but may be superseded by subsequent disclosure. Click the button below to download the IR Presentation. IR PRESENTATION QUARTERLY AND CONFERENCE CALLS Viemed hosts quarterly earnings calls. All replays will be posted following calls. CORPORATE GOVERNANCE Viemed Healthcare follows and maintains high standards of Corporate Governance. The Board of Directors of Viemed Healthcare believes that good governance practices protect long-term shareholder value and ensure that the Company conducts its activities and operations with integrity and in an ethical manner, geared towards shareholders’ best interests. Compensation Committee Charter Charter of the Audit Committee Corporate Governance and Nominating Committee Charter Business Corporations Act Articles Code of Ethics NASDAQ STOCK INFORMATION back to top Your browser does not support iframes. Your browser does not support iframes. Your browser does not support iframes. TSX STOCK INFORMATION back to top Your browser does not support iframes. Your browser does not support iframes. Your browser does not support iframes. INVESTOR CONTACT FORM back to top SIGN UP HERE FOR AN INVESTOR PACK AND INFORMATION If you would like to receive a corporate information package or for someone to contact you directly, please complete the form below and we will get back to you shortly: Name * Surname * Contact Number * Email Address * Comments / Questions * INVESTOR CONTACTS back to top Ticker Symbol Viemed is listed on the Toronto Stock Exchange (TSX) under the ticker symbol VMD Transfer agent & registrar Computershare Investor Services Inc. 2nd Floor, 510 Burrard Street, Vancouver, British Columbia V6C 3A8. Auditor Ernst & Young LLP 701 Poydras Street, Suite 3900 New Orleans, LA 70139 PAY BILL CONTACT US > Compliance Hotline: Please call 1-877-711-1677 © 2018 Viemed. All Rights Reserved. Scroll To Top